Award Title | Agency | Phase | Award amount | Start Date | End Date |
---|---|---|---|---|---|
Novel Therapeutic Strategy for Refractory and Relapse Childhood Acute Leukemia
Apex Therapeutics, Inc. Principal Investigator |
HHS | 1 | $240K | 07/01/13 | 06/30/14 |
Redox protein APE1/Ref-1 as a target for age-related macular degeneration (AMD)
Apex Therapeutics, Inc. Principal Investigator |
HHS | 1 | $225K | 09/30/09 | 06/29/11 |